Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  Asaleo Care Limited    AHY   AU000000AHY8

ASALEO CARE LIMITED

(AHY)
  Report
End-of-day quote. End-of-day quote Australian Stock Exchange - 10/28
0.995 AUD   +2.58%
09/17ASALEO CARE : Appointment of Chief Financial Officer
PU
08/24ASALEO CARE : Change of Director's Interest Notice
PU
08/17ASALEO CARE : First Half Financial Results Media Release
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Asaleo Care : First Half Financial Results Media Release

share with twitter share with LinkedIn share with facebook
08/17/2020 | 07:43pm EDT

Media Release

18 August 2020

Profitable market share growth during a challenging 1H FY20

Asaleo Care today announced its Half Year results for 2020 with an Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) from continuing operations of $49.4 million (1H19 $39.8 million) and a Statutory Net Profit after Tax of $18.8m (1H19 $7.3 million).

Chief Executive Officer and Managing Director, Sid Takla said: "the Company's strong brands, diverse business model and our local manufacturing footprint combined to deliver strong revenue and earnings growth during this challenging period. Solid cash generation during the period also enabled further strengthening of the balance sheet through net debt reduction."

"Our priority has been to ensure all our staff remain safe and healthy during the COVID-19 pandemic. Strict measures have been put in place to ensure all manufacturing sites and distribution centres remain in operation. No closures or downtime have been experienced. We remain vigilant to ensure we can continue to supply our essential goods and have contingency plans in place to deal with issues if they were to arise. Our office-based staff have and continue to, successfully work remotely."

"Pleasingly, our strategy to drive growth with investment in our brands and putting the needs of our customers and consumers first is gaining traction. We have delivered market share growth in all our key categories."

Key Financials

A$ millions

1H20

1H19

Change

Continuing Operations:

Underlying Revenue**

215.0

196.1

9.6%

Underlying EBITDA**

49.4

39.8

24.1%

Underlying EBIT**

36.6

28.3

29.3%

Underlying NPAT **

22.8

15.2

50.0%

Non-recurring expenses after tax***

(0.1)

(2.6)

(96.2%)

Net Profit/(Loss) before Discontinued

22.7

80.2%

Operations

12.6

Loss from Discontinued Operations

(3.9)

(5.2)

(25%)

Statutory Net Profit/(Loss) after Tax

18.8

7.3

157.5%

Underlying Earnings Per Share (EPS)

4.2 cps

2.7 cps

55.6%

Statutory Earnings Per Share

3.5 cps

1.3 cps

169.2%

Dividend

Nil*

*The Directors have determined that there will be no interim dividend.

**This report includes certain non-IFRS financial information (underlying revenue, underlying EBITDA, underlying EBIT and underlying NPAT). This information is considered by Management in assessing the operating performance of the business and has been included for the benefit of investors. References to EBITDA in this release are references to earnings before, interest, tax, depreciation and amortisation and non- recurring items.

***Non-recurring expenses in 1H19 relate to strategic initiatives undertaken in the Company's NZ manufacturing operations.

Asaleo Care Limited

Page 1 of 3

20-32 Westall Road, Springvale Victoria, 3171

ABN 61 154 461 300

www.asaleocare.com

"Consistent with our strategy to focus on businesses that will generate sustainable and superior returns, we announced on 25th June our decision to withdraw from the loss-making NZ Baby Diaper category, including the closure of the Te Rapa manufacturing facility."

BUSINESS SEGMENT RESULTS

B2B

The B2B segment delivered revenue growth of 4.6% during the first half. We experienced significant demand for our products during the initial stages of COVID-19. This resulted from customers ensuring they had adequate stock levels of critical products including soaps, sanitisers, towel and wiping and cleaning products, as well as incontinence products into the aged care sector. Our local (Trans-Tasman) manufacturing footprint enabled us to quickly respond to the surge in demand. As lockdown measures were maintained later in the first half, a drop in away-from-home activity negatively impacted sales to the Hospitality, Office Cleaning and Education sectors. However, this impact was softened by an increase in demand for hygiene consumables in the Healthcare and Food Processing sectors.

Sales of our high margin, proprietary 'Hero Systems' continue to increase. TENA Healthcare revenue increased by 11%, with underlying growth in demand from the residential aged care and in-home care sectors. Tork Professional Hygiene revenue increased 2.5% notwithstanding the COVID-19 lockdown measures adversely impacting end customers. B2B EBITDA was up 17.3% to $24.4m as a result of the higher sales volumes and lower pulp costs. This was partly offset by the weaker local currencies and higher insurance costs.

Retail

Revenue growth was strong in the Retail segment, up 15.6% to $103.6 million with all categories (excluding NZ Baby) experiencing double-digit growth. Whilst the business benefitted from the panic-buying during the early stages of the COVID-19 lockdown in both Australia and New Zealand, this did start to unwind in the later stages of the half.

Pleasingly, our recent increased brand investments, together with the local manufacture of most of our Retail products, enabled us to capitalize on this demand and increase our market share in most categories.

Retail EBITDA increased 31.6% to $25 million. This resulted from strong revenue growth driving high production volumes combined with low pulp costs. These were however, partly offset by weaker local currencies and higher insurance costs.

OUTLOOK

The COVID-19 panic buying that occurred in March and April had a positive impact on the first half result, however we anticipate this will continue to unwind in the second half of the year. The ongoing lockdown measures are also expected to continue to temporarily dampen away-from-home activity and therefore demand in the Professional Hygiene business. These demand drivers, as well as less favourable FX hedged positions and the implementation of brand investment deferred to H2, are expected to impact EBITDA in the second half.

The full year outlook for FY20 remains unchanged, however we now expect Underlying EBITDA to be at the upper end of the $84 - $87 million range. To ensure financial strength during the current COVID-19 uncertainty, our focus will be on further net debt reduction. Accordingly, no interim dividend was declared.

- ENDS -

Asaleo Care Limited

Page 2 of 3

20-32 Westall Road, Springvale Victoria, 3171

ABN 61 154 461 300

www.asaleocare.com

About Asaleo Care (ASX:AHY)

Asaleo Care is a leading personal care and hygiene company that manufactures, markets, distributes and sells personal care and hygiene products throughout Australia, New Zealand and the Pacific Islands. Our portfolio of market-leading brands includes Libra, TENA, Tork, Viti and Orchid. The Sorbent, Purex, Handee Ultra and Deeko brands are owned in New Zealand and Pacific Islands only. The Company has 14 manufacturing and distribution facilities and employs about 650 people who work together to offer products and services which provide care, comfort and confidence every day. For more information visit www.asaleocare.com

Contacts:

INVESTORS:

MEDIA:

Campbell Richards, CFO

Catherine Le, People Communications Manager

P:

+61 411 114 883

P: +61 491 752 281

E:

campbell.richards@asaleocare.com

E: catherine.le@asaleocare.com

Asaleo Care Limited

Page 3 of 3

20-32 Westall Road, Springvale Victoria, 3171

ABN 61 154 461 300

www.asaleocare.com

Disclaimer

Asaleo Care Limited published this content on 18 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 August 2020 22:42:07 UTC


share with twitter share with LinkedIn share with facebook
All news about ASALEO CARE LIMITED
09/17ASALEO CARE : Appointment of Chief Financial Officer
PU
08/24ASALEO CARE : Change of Director's Interest Notice
PU
08/17ASALEO CARE : First Half Financial Results Media Release
PU
08/17ASALEO CARE : First Half 20 Results Presentation
PU
08/17ASALEO CARE : Appendix 4D for the half year ended 30 June 2020
PU
08/11ASALEO CARE : issues voluntary recall of Sorbent facial tissue product in New Ze..
PU
08/10ASALEO CARE : Webcast of 2020 Half Year Results
PU
07/20ASALEO CARE : launches inaugural Reconciliation Action Plan
PU
04/21ASALEO CARE : Results of 2020 AGM - 21 April 2020
PU
03/19ASALEO CARE : Notice of Annual General Meeting/Proxy Form
PU
More news
Financials
Sales 2020 429 M 303 M 303 M
Net income 2020 34,0 M 24,0 M 24,0 M
Net Debt 2020 102 M 71,6 M 71,6 M
P/E ratio 2020 15,3x
Yield 2020 2,31%
Capitalization 540 M 382 M 381 M
EV / Sales 2020 1,49x
EV / Sales 2021 1,43x
Nbr of Employees -
Free-Float 62,9%
Chart ASALEO CARE LIMITED
Duration : Period :
Asaleo Care Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASALEO CARE LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 1,16 AUD
Last Close Price 1,00 AUD
Spread / Highest target 30,7%
Spread / Average Target 17,0%
Spread / Lowest Target -5,53%
EPS Revisions
Managers
NameTitle
Sid Takla Chief Executive Officer, MD & Director
Harry Boon Independent Non-Executive Chairman
Campbell R. Richards Chief Financial Officer
Mats Berencreutz Non-Executive Director
Sue M. Morphet Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
ASALEO CARE LIMITED-6.13%376
KIMBERLY-CLARK CORPORATION-4.01%45 837
UNICHARM CORPORATION33.19%28 170
ESSITY AB-9.41%22 164
HENGAN INTERNATIONAL GROUP COMPANY LIMITED-2.61%8 297
VINDA INTERNATIONAL HOLDINGS LIMITED53.74%3 373